References
- Younossi ZM. Non-alcoholic fatty liver disease-a global public health perspective. J Hepatol. 2018 Nov 8;70(3):pii: S0168-8278(18)32517–0.
- Mann JP, Valenti L, Scorletti E, et al. nonalcoholic fatty liver disease in children. Semin Liver Dis. 2018 Feb;38(1):1–13.
- D’Adamo E, Cali AM, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care. 2010;33:1817–1822.
- Santoro N, Kursawe R, D’Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010;52:1281–1290.
- Miraglia Del Giudice E, Grandone A, Cirillo G, et al. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One. 2011;6:e27933.
- Marzuillo P, Grandone A, Conte M, et al. Novel association between a nonsynonymous variant (R270H) of the G-protein-coupled receptor 120 and liver injury in children and adolescents with obesity. J Pediatr Gastroenterol Nutr. 2014 Oct;59(4):472–475.
- Grandone A, Cozzolino D, Marzuillo P, et al. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children. Pediatr Obes. 2016;11(2):115–119.
- Di Sessa A, Umano GR, Cirillo G, et al. The membrane-bound O-acyltransferase7 rs641738 variant in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2018 Mar 29;67:69–74.
- Mann JP, Goonetilleke R, McKiernan P. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Arch Dis Child. 2015;100(7):673–677.
- Hegarty R, Deheragoda M, Fitzpatrick E, et al. Paediatric fatty liver disease (PeFLD): all is not NAFLD - Pathophysiological insights and approach to management. J Hepatol. 2018 Jun;68(6):1286–1299.
- Alfani R, Vassallo E, De Anseris AG, et al. Pediatric fatty liver and obesity: not always justa matter of non-alcoholic fatty liver disease. Children (Basel). 2018 Dec 13;5(12):169.
- Shashaj B, Bedogni G, Graziani MP, et al. Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. JAMA Pediatr. 2014 Oct;168(10):917–924.
- Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319–334.
- Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018 Jan;67(1):6–19.
- Vajro P, Lenta S, Socha P, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee. J Pediatr Gastroenterol Nutr. 2012;54:700–713.
- Rudolph B, Rivas Y, Kulak S, et al. Yield of diagnostic tests in obese children with an elevated alanine aminotransferase. Acta Paediatr. 2015;104(12):e557–e563.
- Schwimmer JB, Newton KP, Awai HI, et al. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(10):1267–1277.
- Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology. 2006;240:116–129.
- Mancini M, Summers P, Faita F, et al. Digital liver biopsy: bio-imaging of fatty liver for translational and clinical research. World J Hepatol. 2018;10:231–245.